➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Medtronic
McKesson
Baxter
Colorcon

Last Updated: April 17, 2021

DrugPatentWatch Database Preview

Alkem Labs Ltd Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ALKEM LABS LTD, and what generic and branded alternatives to ALKEM LABS LTD drugs are available?

ALKEM LABS LTD has seventy-six approved drugs.

There are eleven tentative approvals on ALKEM LABS LTD drugs.

Summary for Alkem Labs Ltd
US Patents:0
Tradenames:63
Ingredients:63
NDAs:76

Drugs and US Patents for Alkem Labs Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alkem Labs Ltd OLANZAPINE olanzapine TABLET;ORAL 202295-005 Oct 20, 2015 AB RX No No   Start Trial   Start Trial
Alkem Labs Ltd FESOTERODINE FUMARATE fesoterodine fumarate TABLET, EXTENDED RELEASE;ORAL 204827-001 Dec 10, 2015 DISCN No No   Start Trial   Start Trial
Alkem Labs Ltd METFORMIN HYDROCHLORIDE metformin hydrochloride TABLET, EXTENDED RELEASE;ORAL 206145-002 Oct 22, 2018 AB RX No No   Start Trial   Start Trial
Alkem Labs Ltd HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 200737-001 Dec 7, 2012 AA RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Alkem Labs Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alkem Labs Ltd MARINOL dronabinol CAPSULE;ORAL 018651-003 May 31, 1985 6,703,418   Start Trial
Alkem Labs Ltd MARINOL dronabinol CAPSULE;ORAL 018651-001 May 31, 1985 6,703,418   Start Trial
Alkem Labs Ltd MARINOL dronabinol CAPSULE;ORAL 018651-002 May 31, 1985 6,703,418   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Merck
Express Scripts
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.